Cargando…

Proteomic analysis of the chemosensitizing effect of curcumin on CRC cells treated with 5-FU

BACKGROUND: 5-Fluorouracil (5-FU) is one of the most common chemotherapy drugs used to treat colorectal cancer (CRC), which often develops resistance in more than 15% of patients. Curcumin, an active component of Curcuma longa, has been reported to show antitumor activity in CRC and, furthermore, en...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Jingbo, He, Chengyan, Liu, Ning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9729741/
https://www.ncbi.nlm.nih.gov/pubmed/36507511
http://dx.doi.org/10.3389/fmed.2022.1032256
_version_ 1784845534591188992
author Yang, Jingbo
He, Chengyan
Liu, Ning
author_facet Yang, Jingbo
He, Chengyan
Liu, Ning
author_sort Yang, Jingbo
collection PubMed
description BACKGROUND: 5-Fluorouracil (5-FU) is one of the most common chemotherapy drugs used to treat colorectal cancer (CRC), which often develops resistance in more than 15% of patients. Curcumin, an active component of Curcuma longa, has been reported to show antitumor activity in CRC and, furthermore, enhance the effect of chemotherapy against colorectal cancer cells. However, the molecular mechanisms underlying the sensitizing effect of curcumin on 5-FU have not been largely elucidated. In this study, we aimed to systematically investigate the role of curcumin as a chemosensitizer for the treatment of CRC, along with the key events responsible for its pharmaceutical effect, which may lead to better clinical outcomes. METHODS: A high-resolution 2DE-based proteomics approach was used to characterize global protein expression patterns in CRC cells treated with 5-FU both in combination with curcumin or without. The differentially expressed proteins were obtained from the 2DE analysis and subsequently identified by MALDI-TOF MS or nano-ESI-MS/MS, some of which were validated by the Western blot. Intracellular reactive oxygen species (ROS) were measured to assess the change in the redox environment resulting from the drug treatment. RESULTS: A series of proteins with altered abundances were detected and identified by MALDI-TOF or nano-MS/MS. From a total of 512 isolated proteins, 22 proteins were found to be upregulated and 6 proteins were downregulated. Intracellular ROS was significantly elevated after curcumin treatment. Furthermore, mass spectrometry data revealed that some of the proteins appeared to have more oxidized forms upon curcumin treatment, suggesting a direct role for ROS in the chemosensitizing effect of curcumin. CONCLUSION: The effect of curcumin in enhancing chemosensitivity to 5-FU is a complex phenomenon made up of several mechanisms, including enhancement of the intracellular level of ROS. Our findings presented here could provide clues for a further study aimed at elucidating the mechanisms underlying the chemosensitizing effect of curcumin.
format Online
Article
Text
id pubmed-9729741
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-97297412022-12-09 Proteomic analysis of the chemosensitizing effect of curcumin on CRC cells treated with 5-FU Yang, Jingbo He, Chengyan Liu, Ning Front Med (Lausanne) Medicine BACKGROUND: 5-Fluorouracil (5-FU) is one of the most common chemotherapy drugs used to treat colorectal cancer (CRC), which often develops resistance in more than 15% of patients. Curcumin, an active component of Curcuma longa, has been reported to show antitumor activity in CRC and, furthermore, enhance the effect of chemotherapy against colorectal cancer cells. However, the molecular mechanisms underlying the sensitizing effect of curcumin on 5-FU have not been largely elucidated. In this study, we aimed to systematically investigate the role of curcumin as a chemosensitizer for the treatment of CRC, along with the key events responsible for its pharmaceutical effect, which may lead to better clinical outcomes. METHODS: A high-resolution 2DE-based proteomics approach was used to characterize global protein expression patterns in CRC cells treated with 5-FU both in combination with curcumin or without. The differentially expressed proteins were obtained from the 2DE analysis and subsequently identified by MALDI-TOF MS or nano-ESI-MS/MS, some of which were validated by the Western blot. Intracellular reactive oxygen species (ROS) were measured to assess the change in the redox environment resulting from the drug treatment. RESULTS: A series of proteins with altered abundances were detected and identified by MALDI-TOF or nano-MS/MS. From a total of 512 isolated proteins, 22 proteins were found to be upregulated and 6 proteins were downregulated. Intracellular ROS was significantly elevated after curcumin treatment. Furthermore, mass spectrometry data revealed that some of the proteins appeared to have more oxidized forms upon curcumin treatment, suggesting a direct role for ROS in the chemosensitizing effect of curcumin. CONCLUSION: The effect of curcumin in enhancing chemosensitivity to 5-FU is a complex phenomenon made up of several mechanisms, including enhancement of the intracellular level of ROS. Our findings presented here could provide clues for a further study aimed at elucidating the mechanisms underlying the chemosensitizing effect of curcumin. Frontiers Media S.A. 2022-11-24 /pmc/articles/PMC9729741/ /pubmed/36507511 http://dx.doi.org/10.3389/fmed.2022.1032256 Text en Copyright © 2022 Yang, He and Liu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Yang, Jingbo
He, Chengyan
Liu, Ning
Proteomic analysis of the chemosensitizing effect of curcumin on CRC cells treated with 5-FU
title Proteomic analysis of the chemosensitizing effect of curcumin on CRC cells treated with 5-FU
title_full Proteomic analysis of the chemosensitizing effect of curcumin on CRC cells treated with 5-FU
title_fullStr Proteomic analysis of the chemosensitizing effect of curcumin on CRC cells treated with 5-FU
title_full_unstemmed Proteomic analysis of the chemosensitizing effect of curcumin on CRC cells treated with 5-FU
title_short Proteomic analysis of the chemosensitizing effect of curcumin on CRC cells treated with 5-FU
title_sort proteomic analysis of the chemosensitizing effect of curcumin on crc cells treated with 5-fu
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9729741/
https://www.ncbi.nlm.nih.gov/pubmed/36507511
http://dx.doi.org/10.3389/fmed.2022.1032256
work_keys_str_mv AT yangjingbo proteomicanalysisofthechemosensitizingeffectofcurcuminoncrccellstreatedwith5fu
AT hechengyan proteomicanalysisofthechemosensitizingeffectofcurcuminoncrccellstreatedwith5fu
AT liuning proteomicanalysisofthechemosensitizingeffectofcurcuminoncrccellstreatedwith5fu